Last Week’s Important Life Science Headlines

February 25, 2014
/
Class Action Design Defect FDA Litigation Medical Device News Pharmaceuticals Product Liability Recalls Regulatory
/

Life Science Matters

Litigation

Xarelto Lawsuit Filed Over Uncontrollable Internal Bleeding
Neomedic Cases Added to Vaginal Mesh Litigation in W.Va. Federal Court
Endo Puts Aside $520M for Vaginal Mesh Litigation (subscription required)
9^th Circ. Refuses to Revive Novartis Jaw Injury Litigation (subscription required)
FTC Bags $2M False Ad Win Against Diabetes Supplement Co. (subscription required)
J&J Mesh Suits Belong in Federal Court, 10^th Circ. Told (subscription required)
New Philly Mass Tort Program Created for Pelvic Mesh Suits (subscription required)
J&J Wins 1

…
Continue reading...

This Week’s Life Science Headlines

February 14, 2014
/
FDA Litigation Medical Device News Pharmaceuticals Preemption Product Liability Recalls Regulatory Settlements
/

Life Science Matters

Litigation

Mich. Drug Companies Now Less Immune Under Tort Reform (subscription required)
9^th Circ. To Reconsider Its Remand of Teva Painkiller Suit (subscription required)
Medtronic Tells 10^th Circ. Bone Device Suit is Preempted (subscription required)
Unilever to Pay $10M Over Hair Loss Tied to Suave Product (subscription required)
Expert Testimony Barred in Denture-Adhesive Mass Tort (subscription required)
Roche Looks to Sink $2M Accutane Verdict on Appeal (subscription required)
Pfizer Says 2^nd Circ. Can’t Review Lipitor FCA Suit (subscription

…
Continue reading...

This Week’s Science Headlines

January 31, 2014
/
Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Product Liability Regulatory
/

Life Science Matters

Litigation

Byetta Thyroid Cancer Lawsuit Centralization Request Filed with JPML
MDL Arguments Over Centralization of Lipitor Diabetes Cases Postponed
Top DOJ Atty Outline Pharma Fraud Enforcement (subscription required)
Possible Sanctions for Takeda in Actos Bladder Cancer MDL (subscription required)
Hydroxycut False Ad Claims Must Be Clarified, Judge Says (subscription required)
GNC Hit with Suit Claiming Diet Pills Led to Liver Damage (subscription required)
J&J Beats $258M Risperdal Verdict in Split La. High Court (subscription required)
Calif. Court Reverses Preemption of Medtronic

…
Continue reading...

This Week’s Life Science Headlines

January 23, 2014
/
Class Action Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Preemption Product Liability Recalls Regulatory Supplements
/

Life Science Matters

Litigation

Pharma Can Be Liable for Design Negligence: Pa. High Court (subscription required)
Pfizer Escapes Whistleblower Suit Over Lipitor Marketing (subscription required)
23andMe Faces Suit Over Recently Banned DNA Tests (subscription required)
Claims and Classes in Medical Monitoring Cases (subscription required)
Boston Scientific Mesh Lawsuit to Move Forward After SOL Challenge
Motion Filed to Centralize OxyElite Pro Lawsuits in MDL
6^th Circuit Revives Mylan Wrongful Death Suit (subscription required)
Jury Clears Abbott In Tainted Formula Injury Suit (subscription required)
Ethicon

…
Continue reading...

This Week’s Life Science Headlines

January 10, 2014
/
Class Action Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Preemption Product Liability Recalls Regulatory Settlements
/

Life Science Matters

Litigation

GSK Blasts Appeal Bid in Pa. Paxil Venue Dispute (subscription required)
Forest Lab’s Lexapro Causes Fatal Birth Defects, Mom Says (subscription required)
Neutrogena Sunblock Label Suit Not Preempted, Judge Says (subscription required)
Laser Hair Removal Linked to Risks, Growing Number of Lawsuits
Fosamax Femur Fracture Lawsuits Continuing, With Several Trials in 2014
J&J Loses Bid to Nix Levaquin Award in 8th Cir. (subscription required)
NY High Court Mulls Test for Recall-Related Damages (subscription required)
Statute of Limitations for Lipitor Diabetes

…
Continue reading...

This Week’s Life Science Headlines

December 26, 2013
/
FDA Litigation Medical Device News Pharmaceuticals Product Liability Recalls Regulatory
/

Life Science Matters

Litigation

NECC Fungal Meningitis Settlement May Result in $100M Payment
MDL Consolidation for Lipitor Diabetes Lawsuits to be Considered Jan. 30
J&J Risperdal Whistleblower Made Millions in Settlement
Generic Fosamax Users Must Give More Details in MDL (subscription required)
JPML Centralizes Glucosamine False Ad Suits (subscription required)
Boehringer May Face More Sanctions in Pradaxa MDL (subscription required)

Regulatory

…
Continue reading...

This Week’s Life Science Headlines

December 19, 2013
/
Class Action Design Defect FDA Litigation Medical Device News Pharmaceuticals Product Liability Recalls Regulatory Settlements Verdicts
/

Life Science Matters

Litigation

3^rd Circ. Doubts Jurisdiction In Generic-Fosamax Appeal (subscription required)
Mirena IUD Lawsuit Discovery Continues in New Jersey and MDL
Abbott Ordered to Produce “Overdue” Docs in Depakote Lawsuits
J&J Fights Attys’ Pursuit of Confidential Risperdal Docs (subscription required)
Pain-Pump Seller SJO Lied to Get $10M Policy, Insurer Says (subscription required)
Stryker Inks 1^st Settlements in NJ Hip Implant Suits (subscription required)
Eli Lilly Defeats Soldier’s Cymbalta “Brain Zap” Suit (subscription required)
4^th Circ. Questions Basis for Generic-Drug

…
Continue reading...

Despite Reported Risks, Side Effects and Threatened Litigation, Crestor Top Selling Drug

Life Science Matters

According to a report by the research firm IMS Health, (free membership login required) new prescriptions and refills for Crestor, a drug used to lower cholesterol, exceeded all other prescribed drugs in the United States between October 2012 and September 2013. Crestor (rosuvastatin), like Lipitor (atorvastatin) is widely-used to lower cholesterol and belongs to a family of drugs called “statins.” Among the best-selling drugs in the United States, statins use the liver to block the body’s creation of cholesterol, which is a key contributor…
Continue reading...

This Week’s Life Science Headlines

November 15, 2013
/
Design Defect FDA Litigation Medical Device News Nutritional Supplements Pharmaceuticals Preemption Recalls Regulatory Settlements Supplements
/

Life Science Matters

Litigation

Eli Lilly, Others Urge 6^th Circ. To Toss Darvocet Appeal (subscription required)
McNeil Asks Pa. Appeals Court to Boot $10M Motrin Verdict (subscription required)
J&J to Pay $4B to Settle Hip Implant Suits (subscription required)
J&J Trying to Back Out of 77 Risperdal Deals, Plaintiffs Say (subscription required)
Birth Defect Lawyers in Effexor MDL Assigned to Leadership Roles
Final Bard Avaulta Vaginal Mesh Bellweather Trial Set for Dec. 3
Stryker Rejuvenate Hip Attorneys Assigned to leadership Positions in MDL

…
Continue reading...

This Week’s Life Science Headlines

November 7, 2013
/
FDA Medical Device News Pharmaceuticals Recalls Regulatory Settlements Verdicts
/

Life Science Matters

Litigation

…
Continue reading...